CHGCY (Chugai Pharmaceutical Co) Cyclically Adjusted FCF per Share: $0.40 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHGCY Chugai Pharmaceutical Co Ltd CHGCY
89 GF Score
Price $21.61
GF Value $24.68
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Chugai Pharmaceutical Co Cyclically Adjusted FCF per Share?

Chugai Pharmaceutical Co CHGCY -2.44% 89 Cyclically Adjusted FCF per Share is $0.40 as of Jun. 2026. GuruFocus rates CHGCY with a GF Score™ of 89/100 and a GF Value™ of $24.68 (Modestly Undervalued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Chugai Pharmaceutical Co's adjusted free cash flow per share for the three months ended in Jun. 2026 was $0.220. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $0.40 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Chugai Pharmaceutical Co's average Cyclically Adjusted FCF Growth Rate was 23.10% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 28.20% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 26.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Chugai Pharmaceutical Co was 28.90% per year. The lowest was 13.60% per year. And the median was 23.05% per year.

As of today (2026-08-01), Chugai Pharmaceutical Co's current stock price is $21.61. Chugai Pharmaceutical Co's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was $0.40. Chugai Pharmaceutical Co's Cyclically Adjusted Price-to-FCF of today is 54.03.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Chugai Pharmaceutical Co was 197.55. The lowest was 53.01. And the median was 76.49.


Chugai Pharmaceutical Co  (OTCPK:CHGCY) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Chugai Pharmaceutical Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=21.61/0.40
=54.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Chugai Pharmaceutical Co was 197.55. The lowest was 53.01. And the median was 76.49.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Chugai Pharmaceutical Co Cyclically Adjusted FCF per Share Related Terms


Chugai Pharmaceutical Co Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Chugai Pharmaceutical Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chugai Pharmaceutical Co Cyclically Adjusted FCF per Share Chart

Chugai Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.20 0.21 0.26 0.31 0.37

Chugai Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.37 0.37 0.37 0.39 0.40

CHGCY vs LLY, JNJ, ABBV: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - General subindustry, Chugai Pharmaceutical Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chugai Pharmaceutical Co Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chugai Pharmaceutical Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Chugai Pharmaceutical Co's Cyclically Adjusted Price-to-FCF falls into.


CHGCY
89GF Score
Chugai Pharmaceutical Co Ltd CHGCY
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chugai Pharmaceutical Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Chugai Pharmaceutical Co's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.22/113.6000*113.6000
=0.220

Current CPI (Jun. 2026) = 113.6000.

Chugai Pharmaceutical Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 0.047 98.000 0.054
201612 -0.024 98.400 -0.028
201703 0.058 98.100 0.067
201706 0.016 98.500 0.018
201709 0.007 98.800 0.008
201712 0.089 99.400 0.102
201803 0.113 99.200 0.129
201806 0.023 99.200 0.026
201809 0.029 99.900 0.033
201812 -0.046 99.700 -0.052
201903 0.060 99.700 0.068
201906 0.078 99.800 0.089
201909 0.143 100.100 0.162
201912 0.126 100.500 0.142
202003 -0.021 100.300 -0.024
202006 0.056 99.900 0.064
202009 0.202 99.900 0.230
202012 0.179 99.300 0.205
202103 0.041 99.900 0.047
202106 0.134 99.500 0.153
202109 0.156 100.100 0.177
202112 0.233 100.100 0.264
202203 0.092 101.100 0.103
202206 0.361 101.800 0.403
202209 0.035 103.100 0.039
202212 -0.088 104.100 -0.096
202303 0.229 104.400 0.249
202306 0.226 105.200 0.244
202309 0.045 106.200 0.048
202312 0.224 106.800 0.238
202403 0.179 107.200 0.190
202406 0.091 108.200 0.096
202409 0.223 108.900 0.233
202412 0.298 110.700 0.306
202503 0.090 111.100 0.092
202506 0.162 111.700 0.165
202509 0.123 112.000 0.125
202512 0.183 113.000 0.184
202603 0.194 112.700 0.196
202606 0.220 113.600 0.220

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $0.40 mean?
Chugai Pharmaceutical Co (CHGCY) has a Cyclically Adjusted FCF per Share of $0.40 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Chugai Pharmaceutical Co and its competitors.
Is Chugai Pharmaceutical Co's Cyclically Adjusted FCF per Share too high?
Chugai Pharmaceutical Co's current Cyclically Adjusted FCF per Share is $0.40. Overall, Chugai Pharmaceutical Co has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Chugai Pharmaceutical Co's Cyclically Adjusted FCF per Share compare to LLY and JNJ?
Chugai Pharmaceutical Co's Cyclically Adjusted FCF per Share of $0.40 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Chugai Pharmaceutical Co and its competitors. Chugai Pharmaceutical Co's current Cyclically Adjusted FCF per Share is $0.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chugai Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Chugai Pharmaceutical Co (CHGCY) is currently considered Modestly Undervalued. The stock's GF Value™ is $24.68, compared to a current price of $21.61 — trading 12.4% below its estimated fair value. The current Cyclically Adjusted FCF per Share is $0.40. Chugai Pharmaceutical Co's overall GF Score™ is 89/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Chugai Pharmaceutical Co (CHGCY), the current Cyclically Adjusted FCF per Share is $0.40 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Chugai Pharmaceutical Co (CHGCY) Overvalued in 2026?

Based on GuruFocus' analysis, Chugai Pharmaceutical Co stock appears to be undervalued. The current stock price of $21.61 is trading 12.4% below its estimated GF Value™ of $24.68. GuruFocus considers Chugai Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for CHGCY:

  • Cyclically Adjusted FCF per Share: $0.40
  • GF Value™: $24.68 vs. price of $21.61 (12.4% below fair value)
  • GF Score™: 89/100 with 1 warning sign

No single metric tells the full story. See the CHGCY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Chugai Pharmaceutical Co Business Description

Address 2-1-1 Muromachi, Nihonbashi, 12th Floor, Nihonbashi Mitsui Tower, Chuo-ku, Tokyo, JPN, 103-8324
Chugai Pharmaceutical is a Japanese drug developer and subsidiary of Roche Holding, which owns roughly 60% of the company. Founded in 1925, Chugai deals primarily in the Japanese market, where it generates roughly half of its revenue. It has been the leader in Japan's oncology market for the past decade, largely due to drugs licensed from its parent's portfolio. The company also develops its own innovative medicines. It is an industry leader in antibody technology with several flagship therapies, including Hemlibra (hemophilia), Actemra (rheumatoid arthritis, covid), Foundayo (oral obesity pill), and Nemluvio (atopic dermatitis, prurigo nodularis).
89GF Score

Get the complete analysis for CHGCY

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$21.61
Price
$24.68
GF Value